Cargando…

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies

COVID-19 pandemic is a global public health emergency. Despite extensive research, there are still few effective treatment options available today. Neutralizing-antibody-based treatments offer a broad range of applications, including the prevention and treatment of acute infectious diseases. Hundred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Mingtao, Gan, Hui, Liang, Zhiman, Liu, Li, Liu, Qiwen, Mai, Yiyin, Chen, Huihuang, Lei, Baoying, Yu, Shangwei, Chen, Huihui, Zheng, Peiyan, Sun, Baoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060843/ https://www.ncbi.nlm.nih.gov/pubmed/37007494 http://dx.doi.org/10.3389/fmicb.2023.1122868

Ejemplares similares

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Functional epitopes and neutralizing antibodies of vaccinia virus
por: Peng, Fenghao, et al.
Publicado: (2023)

Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
por: Yan, Li-na, et al.
Publicado: (2022)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
por: Facciuolo, Antonio, et al.
Publicado: (2023)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
por: Zhao, Shaojuan, et al.
Publicado: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
por: Lassaunière, Ria, et al.
Publicado: (2021)

Internet of medical things-enabled CRISPR diagnostics for rapid detection of SARS-CoV-2 variants of concern
por: Lin, Huihuang, et al.
Publicado: (2022)

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
por: Wang, Shuang, et al.
Publicado: (2020)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

Novel nutritional indicator as predictors among subtypes of lung cancer in diagnosis
por: Li, Haiyang, et al.
Publicado: (2023)

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies
por: Tsai, Keng-Chang, et al.
Publicado: (2021)

Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
por: Cheng, Zhangkai J., et al.
Publicado: (2022)

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody
por: Li, Yizhe, et al.
Publicado: (2023)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
por: Cheng, Zhangkai Jason, et al.
Publicado: (2021)

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities
por: Tian, Xiaodong, et al.
Publicado: (2021)

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
por: Zhou, Guangyu, et al.
Publicado: (2020)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
por: Liu, Kuan-Ting, et al.
Publicado: (2022)

Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Lee, Beomki, et al.
Publicado: (2022)

The development of neutralizing antibodies against SARS-CoV-2 and their common features
por: Liu, Liu Daisy, et al.
Publicado: (2020)

Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Development of an Effective Neutralizing Antibody Assay for SARS-CoV-2 Diagnosis
por: Liu, Zhigang, et al.
Publicado: (2023)

Enhanced Potency of a Broad H7N9-Neutralizing Antibody HNIgGA6 Through Structure-Based Design
por: Chen, Cong, et al.
Publicado: (2020)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Correlation between immune‐related Tryptophan‐Kynurenine pathway and severity of severe pneumonia and inflammation‐related polyunsaturated fatty acids
por: Guo, Baojun, et al.
Publicado: (2023)

Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
por: Zhou, Dongyan, et al.
Publicado: (2021)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mb67rgu3a82dbeb02uf3b8kku5